Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiufang Mi

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Annals of Translational Medicine|March 14, 2022
Modified microvessel density based on perfusion distance: a preferable NSCLC prognostic factorYinghui Tong, Dihong Yang, Xiufang Mi, et al.
Cancer Chemotherapy and Pharmacology|July 30, 2024
Population pharmacokinetic and exposure-toxicity analyses of nab-paclitaxel after pegylated recombinant human granulocyte colony-stimulating factor administration in patients with metastatic breast cancerDihong Yang, Gaoqi Xu, Haiying Ding, et al.
Plos One|May 15, 2024
Cost-effectiveness analysis of tislelizumab plus chemotherapy as the first-line treatment for advanced or metastatic oesophageal squamous cell carcinoma in ChinaChaoneng He, Xiufang Mi, Gaoqi Xu, et al.
Annals of Translational Medicine|April 18, 2022
Pharmacist-led standardization of total parenteral nutrition improves postoperative nutritional status in colorectal cancer patientsYinghui Tong, Jiao Sun, Wenxiu Xin, et al.
European Journal of Clinical Pharmacology|June 21, 2024
Population pharmacokinetics of free and liposome-encapsulated mitoxantrone in patients with relapsed/refractory lymphoma or small cell lung cancerGaoqi Xu, Dihong Yang, Haiying Ding, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Annals of Translational Medicine|March 14, 2022
Modified microvessel density based on perfusion distance: a preferable NSCLC prognostic factorYinghui Tong, Dihong Yang, Xiufang Mi, et al.
Cancer Chemotherapy and Pharmacology|July 30, 2024
Population pharmacokinetic and exposure-toxicity analyses of nab-paclitaxel after pegylated recombinant human granulocyte colony-stimulating factor administration in patients with metastatic breast cancerDihong Yang, Gaoqi Xu, Haiying Ding, et al.
Plos One|May 15, 2024
Cost-effectiveness analysis of tislelizumab plus chemotherapy as the first-line treatment for advanced or metastatic oesophageal squamous cell carcinoma in ChinaChaoneng He, Xiufang Mi, Gaoqi Xu, et al.
Annals of Translational Medicine|April 18, 2022
Pharmacist-led standardization of total parenteral nutrition improves postoperative nutritional status in colorectal cancer patientsYinghui Tong, Jiao Sun, Wenxiu Xin, et al.
European Journal of Clinical Pharmacology|June 21, 2024
Population pharmacokinetics of free and liposome-encapsulated mitoxantrone in patients with relapsed/refractory lymphoma or small cell lung cancerGaoqi Xu, Dihong Yang, Haiying Ding, et al.
Pageof 2